Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use

From the end of 2019, the world population has been faced the spread of the novel coronavirus SARS-CoV-2 responsible for COVID-19 infection. In approximately 14% of the patients affected by the novel coronavirus, the infection progresses with the development of pneumonia that requires mechanical ven...

Descripción completa

Detalles Bibliográficos
Autores principales: Bari, Elia, Ferrarotti, Ilaria, Saracino, Laura, Perteghella, Sara, Torre, Maria Luisa, Corsico, Angelo Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226831/
https://www.ncbi.nlm.nih.gov/pubmed/32283815
http://dx.doi.org/10.3390/cells9040924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226831/
https://www.ncbi.nlm.nih.gov/pubmed/32283815
http://dx.doi.org/10.3390/cells9040924

Ejemplares similares